Jennifer Jaroscak to Humans
This is a "connection" page, showing publications Jennifer Jaroscak has written about Humans.
Connection Strength
0.075
-
Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood. 2003 Jun 15; 101(12):5061-7.
Score: 0.008
-
Anakinra utilization in refractory pediatric CAR T-cell associated toxicities. Blood Adv. 2022 06 14; 6(11):3398-3403.
Score: 0.008
-
Apparent coexistence of ETV6::RUNX1 and KMT2A::MLLT3 fusions due to a nonproductive KMT2A rearrangement in B-ALL. Leuk Lymphoma. 2022 09; 63(9):2243-2246.
Score: 0.008
-
Acute Myeloid Leukemia Case after Gene Therapy for Sickle Cell Disease. N Engl J Med. 2022 01 13; 386(2):138-147.
Score: 0.008
-
Outcomes Using Narrowband UVB Phototherapy for Acute Cutaneous Graft Versus Host Disease in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients. J Pediatr Hematol Oncol. 2021 01; 43(1):e151-e153.
Score: 0.007
-
Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric Patients. Biol Blood Marrow Transplant. 2019 03; 25(3):556-561.
Score: 0.006
-
The effect of bone marrow graft composition on pediatric bone marrow transplantation outcomes. Pediatr Transplant. 2018 12; 22(8):e13287.
Score: 0.006
-
A trial of unrelated donor marrow transplantation for children with severe sickle cell disease. Blood. 2016 11 24; 128(21):2561-2567.
Score: 0.005
-
Alemtuzumab based reduced intensity transplantation for pediatric severe aplastic anemia. Pediatr Blood Cancer. 2015 Jul; 62(7):1270-6.
Score: 0.005
-
Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes. Blood. 2010 Dec 02; 116(23):5045-9.
Score: 0.003
-
Clinical and immunologic outcomes following haplocompatible donor lymphocyte infusions. Bone Marrow Transplant. 2009 Dec; 44(12):805-12.
Score: 0.003
-
Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults. Br J Haematol. 2007 Nov; 139(3):464-74.
Score: 0.003
-
Recipient-specific tolerance after HLA-mismatched umbilical cord blood stem cell transplantation. Transplantation. 2005 Nov 15; 80(9):1316-22.
Score: 0.003
-
Hematopoietic recovery after unrelated umbilical cord-blood allogeneic transplantation in adults treated with in vivo stem cell factor (R-MetHuSCF) and filgrastim administration. Leuk Res. 2003 Mar; 27(3):215-20.
Score: 0.002